Immunofluorescence staining indicated that expression levels of C-Caspase-1, N-GSDMD, and NLRP3 were significantly elevated in tumor tissues treated with THZO NWs, with even greater enhancement in the THZO + US group (Fig. 6m). This evidence concerns the gene CASP1 and neoplasm.